United Kingdom· GB-APID-12948911000001102

Atripla 600mg/200mg/245mg tablets

A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz + emtricitabine + tenofovir disoproxil, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about efavirenz + emtricitabine + tenofovir disoproxilAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
8 of them publish a price we can compare per daily dose

Search emtricitabine, tenofovir disoproxil and efavirenz products by name

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Efavirenz + Emtricitabine + Tenofovir disoproxil
Manufacturer: Gilead Sciences Ltd
Country: United Kingdom (GB)
ATC code: J05AR06
ATC class: Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 3

gtin
5391507140029
gtin
05391507145161
gtin
05391507145178

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check emtricitabine, tenofovir disoproxil and efavirenz against other medicines How interaction checks work

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil and efavirenz in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil and efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
Finland · Fatrino
France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f5d9df26-a83d-4789-9422-d3a7a7800e0e
GET /v1/drugs/f5d9df26-a83d-4789-9422-d3a7a7800e0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "12948911000001102",
  "desc": "Atripla 600mg/200mg/245mg tablets (Gilead Sciences Ltd)",
  "form": "Oral tablet",
  "vpid": "13005311000001104",
  "source": "dmd",
  "vtm_id": "30934511000001108",
  "strength": "245 mg",
  "substance": "Efavirenz + Emtricitabine + Tenofovir disoproxil",
  "ingredient": "Tenofovir disoproxil",
  "supplier_code": "2572301000001107"
}

API reference MCP server Plans

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console